• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Sana Biotechnology (SANA)

Common Shares
Sell: $4.43|Buy: $4.45|Change: 0.14 (-3.11%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas withunmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Address

251 Little Falls Drive
County of New Castle
Wilmington
DE
USA
19808

Telephone

+1 206 701-7914

Website

https://www.sana.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Sana Biotechnology Inc Third Quarter Earnings Results for 20262026-11-06T00:00:00
Sana Biotechnology Inc Second Quarter Earnings Results for 20262026-08-11T16:05:00
Sana Biotechnology Inc Annual General Meeting for 20262026-06-05T09:00:00
Sana Biotechnology Inc First Quarter Earnings Results for 20262026-05-08T00:00:00
Sana Biotechnology Inc Fourth Quarter Earnings Results for 20252026-03-17T00:00:00
Sana Biotechnology Inc Annual Report for 20252026-03-17T00:00:00
8th Annual Evercore Healthcare Conference2025-12-03T14:35:00
Citi's 2025 Global Healthcare Conference2025-12-02T14:30:00

Previous key dates

NameKey Date
8th Annual Evercore Healthcare Conference2025-12-03T14:35:00
Citi's 2025 Global Healthcare Conference2025-12-02T14:30:00
TD Cowen Immunology & Inflammation Summit2025-11-12T13:30:00
Sana Biotechnology Inc Third Quarter Earnings Results for 20252025-11-06T00:00:00
HC Wainwright 27th Annual Global Investment Conference2025-09-09T09:30:00
the Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-08T11:30:00
2025 Wells Fargo Healthcare Conference2025-09-04T08:00:00
Citi's 2025 Biopharma Back-to-School Conference2025-09-02T15:15:00
Sana Biotechnology Inc Second Quarter Earnings Results for 20252025-08-11T16:05:00
Sana Biotechnology at Goldman Sachs 46th Annual Global Healthcare Conference2025-06-10T08:40:00
Sana Biotechnology Inc Annual General Meeting for 20252025-06-05T09:00:00
Sana Biotechnology at jefferies global healthcare conference2025-06-04T14:35:00
BofA Securities 2025 Healthcare Conference2025-05-13T09:20:00
Sana Biotechnology Inc First Quarter Earnings Results for 20252025-05-08T00:00:00
Sana Biotechnology Inc Fourth Quarter Earnings Results for 20242025-03-17T00:00:00
Sana Biotechnology Inc Annual Report for 20242025-03-17T00:00:00
Cowen 45(th) Annual Health Care Conference2025-03-03T15:10:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-15T09:00:00
Sana Biotechnology at 7th Annual Evercore HealthCONx Conference 20242024-12-04T14:35:00
Sana Biotechnology at Citi’s 2024 Global Healthcare Conference2024-12-03T14:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.